Statistical analyses were performed by a study biostatistician (D
Statistical analyses were performed by a study biostatistician (D.A.L.), and were independently confirmed by a biostatistician not affiliated with the study (M.P.). compared to placebo around the CAPS hyperarousal symptom cluster.GR205171was well-tolerated, with no discontinuations due to adverse events. CSF SP concentrations were positively correlated with baseline CAPS severity. The selective NK1R antagonistGR205171had fewer adverse effects but was not significantly superior to placebo in the short-term treatment Cefotaxime sodium of chronic PTSD. (ClinicalTrials.govIdentifier: NCT 00211861,NCT 00383786) Keywords:NK1, material P, PTSD, clinical trial, randomized == INTRODUCTION == Despite the enormous societal impact of posttraumatic stress disorder (PTSD), few pharmacotherapies are associated with consistently robust improvements in all three symptom domains (i.e., reexperiencing, avoidance/emotional numbing, and hyperarousal). U.S. practice guidelines have endorsed cognitive-behavioral therapy (CBT) and selective serotonin reuptake inhibitors Cefotaxime sodium…